Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Analysts expect ImmunoPrecise Antibodies to report an earnings per share (EPS) of $-0.06. Investors in ImmunoPrecise Antibodies are eagerly awaiting the company's announcement, hoping for news of ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Acumen Pharmaceuticals has concluded enrolment for its multi-centre, double-blind Phase II ALTITUDE-AD trial of humanised ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals potential growth. Read why RADX stock is a Hold.

Introduction Biosimilar monoclonal antibodies (mAbs) are biologic drugs designed to be highly similar to already approved reference monoclonal ...

The pair appeared on the Stick To Football podcast, brought to you by Sky Bet, where Caragh opened up about life with her ...

Despite missing its primary endpoint, Equillium is pushing ahead with itolizumab citing its complete response by day 99.

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

The average patient takes 13 years to be diagnosed as the signs are often subtle and can easily be mistaken for other, less ...